These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
576 related articles for article (PubMed ID: 25369773)
1. Integrin-targeted delivery into cancer cells of a Pt(IV) pro-drug through conjugation to RGD-containing peptides. Massaguer A; González-Cantó A; Escribano E; Barrabés S; Artigas G; Moreno V; Marchán V Dalton Trans; 2015 Jan; 44(1):202-12. PubMed ID: 25369773 [TBL] [Abstract][Full Text] [Related]
2. An integrin-targeted photoactivatable Pt(IV) complex as a selective anticancer pro-drug: synthesis and photoactivation studies. Gandioso A; Shaili E; Massaguer A; Artigas G; González-Cantó A; Woods JA; Sadler PJ; Marchán V Chem Commun (Camb); 2015 Jun; 51(44):9169-72. PubMed ID: 25947177 [TBL] [Abstract][Full Text] [Related]
3. RGD-modified polymeric micelles as potential carriers for targeted delivery to integrin-overexpressing tumor vasculature and tumor cells. Wang Y; Wang X; Zhang Y; Yang S; Wang J; Zhang X; Zhang Q J Drug Target; 2009 Jul; 17(6):459-67. PubMed ID: 19527117 [TBL] [Abstract][Full Text] [Related]
4. Cyclic RGD peptide-conjugated polyplex micelles as a targetable gene delivery system directed to cells possessing alphavbeta3 and alphavbeta5 integrins. Oba M; Fukushima S; Kanayama N; Aoyagi K; Nishiyama N; Koyama H; Kataoka K Bioconjug Chem; 2007; 18(5):1415-23. PubMed ID: 17595054 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of RGD conjugated with Ketoprofen/Naproxen and radiolabeled with [ Mohammadi R; Shokri B; Shamshirian D; Zarghi A; Shahhosseini S Daru; 2020 Jun; 28(1):87-96. PubMed ID: 31845157 [TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo evaluation of doxorubicin conjugates with the divalent peptide E-[c(RGDfK)2] that targets integrin alphavbeta3. Ryppa C; Mann-Steinberg H; Fichtner I; Weber H; Satchi-Fainaro R; Biniossek ML; Kratz F Bioconjug Chem; 2008 Jul; 19(7):1414-22. PubMed ID: 18578486 [TBL] [Abstract][Full Text] [Related]
7. FITC-conjugated cyclic RGD peptides as fluorescent probes for staining integrin αvβ3/αvβ5 in tumor tissues. Zheng Y; Ji S; Czerwinski A; Valenzuela F; Pennington M; Liu S Bioconjug Chem; 2014 Nov; 25(11):1925-41. PubMed ID: 25312799 [TBL] [Abstract][Full Text] [Related]
8. alpha(v)beta(3) Integrin-targeting radionuclide therapy and imaging with monomeric RGD peptide. Yoshimoto M; Ogawa K; Washiyama K; Shikano N; Mori H; Amano R; Kawai K Int J Cancer; 2008 Aug; 123(3):709-15. PubMed ID: 18498129 [TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo evaluation of a paclitaxel conjugate with the divalent peptide E-[c(RGDfK)2] that targets integrin alpha v beta 3. Ryppa C; Mann-Steinberg H; Biniossek ML; Satchi-Fainaro R; Kratz F Int J Pharm; 2009 Feb; 368(1-2):89-97. PubMed ID: 18992308 [TBL] [Abstract][Full Text] [Related]
10. Recent Approaches to Platinum(IV) Prodrugs: A Variety of Strategies for Enhanced Delivery and Efficacy. Najjar A; Rajabi N; Karaman R Curr Pharm Des; 2017; 23(16):2366-2376. PubMed ID: 28155621 [TBL] [Abstract][Full Text] [Related]
11. Toward Angiogenesis Inhibitors Based on the Conjugation of Organometallic Platinum(II) Complexes to RGD Peptides. Zamora A; Gandioso A; Massaguer A; Buenestado S; Calvis C; Hernández JL; Mitjans F; Rodríguez V; Ruiz J; Marchán V ChemMedChem; 2018 Sep; 13(17):1755-1762. PubMed ID: 29932312 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of RGD peptidomimetic-paclitaxel conjugates bearing lysosomally cleavable linkers. Dal Corso A; Caruso M; Belvisi L; Arosio D; Piarulli U; Albanese C; Gasparri F; Marsiglio A; Sola F; Troiani S; Valsasina B; Pignataro L; Donati D; Gennari C Chemistry; 2015 Apr; 21(18):6921-9. PubMed ID: 25784522 [TBL] [Abstract][Full Text] [Related]
13. High-Affinity RGD-Knottin Peptide as a New Tool for Rapid Evaluation of the Binding Strength of Unlabeled RGD-Peptides to α Bernhagen D; De Laporte L; Timmerman P Anal Chem; 2017 Jun; 89(11):5991-5997. PubMed ID: 28492301 [TBL] [Abstract][Full Text] [Related]
14. Noninvasive visualization and quantification of tumor αVβ3 integrin expression using a novel positron emission tomography probe, 64Cu-cyclam-RAFT-c(-RGDfK-)4. Jin ZH; Furukawa T; Galibert M; Boturyn D; Coll JL; Fukumura T; Saga T; Dumy P; Fujibayashi Y Nucl Med Biol; 2011 May; 38(4):529-40. PubMed ID: 21531290 [TBL] [Abstract][Full Text] [Related]
15. Glycosylated Platinum(IV) Complexes as Substrates for Glucose Transporters (GLUTs) and Organic Cation Transporters (OCTs) Exhibited Cancer Targeting and Human Serum Albumin Binding Properties for Drug Delivery. Ma J; Wang Q; Huang Z; Yang X; Nie Q; Hao W; Wang PG; Wang X J Med Chem; 2017 Jul; 60(13):5736-5748. PubMed ID: 28603992 [TBL] [Abstract][Full Text] [Related]
16. RGD-conjugated solid lipid nanoparticles inhibit adhesion and invasion of αvβ3 integrin-overexpressing breast cancer cells. Shan D; Li J; Cai P; Prasad P; Liu F; Rauth AM; Wu XY Drug Deliv Transl Res; 2015 Feb; 5(1):15-26. PubMed ID: 25787336 [TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of novel dual-cyclic RGD peptides for α Liu J; Cheng X; Tian X; Guan D; Ao J; Wu Z; Huang W; Le Z Bioorg Med Chem Lett; 2019 Apr; 29(7):896-900. PubMed ID: 30732943 [TBL] [Abstract][Full Text] [Related]
18. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression. Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848 [TBL] [Abstract][Full Text] [Related]